J&J Ordered to Pay Billions to Whistleblower as Risperdal Lawsuit Claims Continue to Be Filed

Published on December 2, 2013 by Laurie Villanueva

Text-Size:A A A+


A 74-year old retired pharmacist who provided vital information about Johnson & Johnson’s marketing of a drug named in Risperdal lawsuit claims to the U.S. government will be granted part of a $27.5 million settlement.

According to a report from the Chicago Tribune, this award was part of a $2.2 billion settlement with Johnson & Johnson, which was reached after an investigation from the U.S. Department of Justice found that the company promoted the medication, along with certain others, to elderly patients with dementia and children prior to the U.S. Food and Drug Administration (FDA)’s approval of Risperdal for pediatric uses in 2006. The settlement was reached on November 4th and involved criminal and civil charges brought against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., recent reports indicate.

In this probe from the U.S. government, federal prosecutors also accused the companies of marketing Risperdal to children despite its knowledge of side effects that include but are not limited to gynecomastia, a condition categorized by male breast growth.

Risperdal Gynecomastia Lawsuits Continue to Mount in Pennsylvania Litigation

Meanwhile, court documents from November 2013 show at least 250 Risperdal gynecomastia lawsuits filed in a consolidated proceeding underway in the Philadelphia Court of Common Pleas. These cases were filed on behalf of men and young boys who developed this complication after taking the atypical anti-psychotic medication.

Plaintiffs involved in lawsuits over the medication similarly allege that the manufacturer of this medication, which is prescribed to treat such conditions as bipolar disorder and schizophrenia in adults and adolescents and irritability in young children with autism, failed to adequately warn doctors and patients about its product’s risk for side effects.

A Bloomberg.com report from 2012 indicates that Johnson & Johnson settled at least five Risperdal lawsuits that year.

Learn More about Risperdal Lawsuits

If you or a man you love experienced Risperdal gynecomastia complications, you may be eligible to receive compensation for out-of-pocket medical expenses, lost wages and other damages incurred by your injuries. Call an attorney at Bernstein Liebhard LLP for more information at .